Chris Harley-Martin, former Global Head of Business Development at GSK Consumer Health and now Senior Advisor with Alantra, continues off from his previous conversation with how sellers think about evaluating divestitures, regional differences in consumer health between the US and EU, and asset-light platform models with the emergence of third-party vendors to manage the “blocking and tackling” while management focuses on strategy.